Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc and Myo-inositol in Paediatric Obesity
NCT03283813Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Feb 2018
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in obesity and insulin resistance (IR) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Primary endpoint: Homeostasis Model Assessment of Insulin Resistance at 3 months. Started Feb 2018; status: completed.
02
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT03283813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283813.